Surgery Versus Perioperative Chemotherapy In Non Metastatic Muscle Invasive Bladder Carcinoma

Surgery Versus Perioperative Chemotherapy In Non Metastatic Muscle Invasive Bladder Carcinoma

According to treatment guidelines of urinary bladder carcinoma, using Neoadjuvent chemotherapy followed by radical cystectomy is the standard treatment which improve overall survival and progression free survival. This study is conducted to compare effect of (1) neoagjuvent chemotherapy followed...

Full description

Bibliographic Details
Main Authors:	Sarah Ali, Mamdouh El Sherbiny, Mohamed Aly El- Wakil, Ahmed Shaban
Format:	Article
Language:	English
Published:	Beni-Suef University, Faculty of Medicine 2022-01-01
Series:	Egyptian Journal of Medical Research
Subjects:	neoadjuvant adjuvant radical cystectomy pfs os
Online Access:	https://ejmr.journals.ekb.eg/article_221834_d7d574d3f0341c03cb6858d9cb44511e.pdf

Similar Items

Neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer: The likelihood of initiation and completion
by: Ahmed Eldefrawy, et al.
Published: (2012-01-01)

Predicting Complete Response to Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
by: Hiroko Miyagi, et al.
Published: (2022-12-01)

Cystectomy vs. bladder preservation after neoadjuvant chemotherapy in muscle-invasive bladder cancer: A tertiary medical center experience
by: Ibrahim El Halabi, et al.
Published: (2020-01-01)

The Current State of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
by: Oktay Üçer
Published: (2016-04-01)

Radical Cystectomy is the best choice for most patients with muscle-invasive bladder cancer? Opinion: No
by: Timur Mitin

Radical Cystectomy is the best choice for most patients with muscle-invasive bladder cancer? Opinion: Yes
by: Leonardo L. Monteiro, et al.

Neoadjuvant chemotherapy versus cystectomy in management of stages II, and III urinary bladder cancer
by: Mohammed A. Osman, et al.
Published: (2014-12-01)

Factors associated with utilization of neoadjuvant chemotherapy in charlson comorbidity zero non-metastatic muscle-invasive bladder cancer patients
by: Daniel Au, et al.
Published: (2021-07-01)

Comparison of trimodality therapy and neoadjuvant chemotherapy combined with radical cystectomy for the survival of muscle-invasive bladder cancer: a population-based analysis
by: Yi-Xin Zhou, et al.
Published: (2023-10-01)

Impacts of Neoadjuvant Chemotherapy on Perioperative Outcomes in Patients with Bladder Cancer Treated with Radical Cystectomy: A Single High-Volume Center Experience
by: Flavia Proietti, et al.
Published: (2024-02-01)

Risk and predictors of patients receiving neoadjuvant chemotherapy followed by radical cystectomy or transurethral resection alone for muscle-invasive bladder cancer: A single-institute experience
by: Pei-Jhang Chiang, et al.
Published: (2022-01-01)

Surface-Enhanced Raman Spectroscopy of Pretreated Plasma Samples Predicts Disease Recurrence in Muscle-Invasive Bladder Cancer Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy
by: Qian H, et al.
Published: (2022-04-01)

Does Time to Adjuvant Chemotherapy after Radical Cystectomy Affect Survival in Muscle Invasive Bladder Cancer? A Systematic Review
by: Shane Kronstedt, et al.
Published: (2022-11-01)

Approaches to Clinical Complete Response after Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer: Possibilities and Limitations
by: Hye Won Lee, et al.
Published: (2023-02-01)

Referral for “Neoadjuvant Chemotherapy” for Muscle-Invasive Bladder Cancer to a Multidisciplinary Board: Patterns, Management and Outcomes
by: Dellis A, et al.
Published: (2021-07-01)

Antibiotics Modulate Chemotherapy Efficacy in Patients with Esophageal Cancer
by: Wu C, et al.
Published: (2020-06-01)

Survival Outcomes of Patients with Pathologically Proven Positive Lymph Nodes at Time of Radical Cystectomy with or without Neoadjuvant Chemotherapy
by: Guillaume Ploussard, et al.
Published: (2020-06-01)

High-risk bladder cancer: improving outcomes with perioperative chemotherapy
by: Daniel Y.C. Heng, et al.
Published: (2011-12-01)

High-risk bladder cancer: improving outcomes with perioperative chemotherapy
by: Daniel Y.C. Heng, et al.
Published: (2011-12-01)

The impact of chemotherapy-naïve open radical cystectomy delay and perioperative transfusion on the recurrence-free survival: A perioperative parameters-based nomogram
by: Ahmed M. Harraz, et al.
Published: (2024-04-01)

Combined Modality Bladder-Sparing Therapy for Muscle-Invasive Bladder Cancer: How (Should) We Do It? A Narrative Review
by: Artur Lemiński, et al.
Published: (2023-02-01)

Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer and Its Impact on Surgical Morbidity and Oncological Outcomes: A Real-World Experience
by: Thanh-Tuan Nguyen, et al.
Published: (2018-09-01)

Clinical application and efficacy analysis of partial cystectomy combined with intravesical chemotherapy in muscle-invasive bladder cancer
by: Bin Zhang, et al.
Published: (2023-05-01)

Clinical Outcomes of Neoadjuvant Versus Adjuvant Chemotherapy on Muscle-invasive Bladder Cancer
by: DENG Kangli, et al.
Published: (2019-04-01)

Survival Benefits of Adjuvant Chemotherapy for Positive Soft Tissue Surgical Margins Following Radical Cystectomy in Bladder Cancer with Extravesical Extension
by: Prithvi B. Murthy, et al.
Published: (2023-03-01)

Efficacy and safety of metformin in combination with chemotherapy in cancer patients without diabetes: systematic review and meta-analysis
by: Kang Yang, et al.
Published: (2023-07-01)

Open versus Robot-Assisted Radical Cystectomy for the Treatment of pT4a Bladder Cancer: Comparison of Perioperative Outcomes
by: Davide Perri, et al.
Published: (2024-03-01)

Lymph node dissection during laparoscopic (LRC) and open (ORC) radical cystectomy due to muscle invasive bladder urothelial cancer (pT2-3, TCC)
by: Krzysztof Krasnicki, et al.
Published: (2011-09-01)

Neoadjuvant or adjuvant chemotherapy: what is the best treatment of muscle invasive bladder cancer?
by: Nabil Ismaili, et al.
Published: (2011-09-01)

Clinical efficacy analysis of partial cystectomy and radical cystectomy in the treatment of muscle-invasive sarcomatoid carcinoma of the urinary bladder
by: Jiansheng Xiao, et al.
Published: (2024-02-01)

Current and Future Landscape of Perioperative Treatment for Muscle-Invasive Bladder Cancer
by: Jorge Esteban-Villarrubia, et al.
Published: (2023-01-01)

Role of Perioperative Immune Checkpoint Inhibitors in Muscle Invasive Bladder Cancer
by: Saachi Chhaya, et al.
Published: (2023-01-01)

Effect of Neoadjuvant Chemotherapy on Complications, in-Hospital Mortality, Length of Stay and Total Hospital Costs in Bladder Cancer Patients Undergoing Radical Cystectomy
by: Benedikt Hoeh, et al.
Published: (2022-02-01)

Comparison of responses to neoadjuvant and adjuvant chemotherapies in muscle-invasive bladder cancer
by: Serhat Sekmek, et al.
Published: (2023-11-01)

Oncological outcomes of visibly complete transurethral resection prior to neoadjuvant chemotherapy for bladder cancer
by: Bryce Baird, et al.
Published: (2023-08-01)

Diminishing the Gender-Related Disparity in Survival among Chemotherapy Pre-Treated Patients after Radical Cystectomy—A Multicenter Observational Study
by: Krystian Kaczmarek, et al.
Published: (2023-02-01)

Comparing Robotic-Assisted to Open Radical Cystectomy in the Management of Non-Muscle-Invasive Bladder Cancer: A Propensity Score Matched-Pair Analysis
by: Etienne Courboin, et al.
Published: (2023-09-01)

Prediction of pathological response following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: the PRE-PREVENCYS trial
by: F. J. Hinsenveld, et al.
Published: (2021-10-01)

Negative impact of antibiotic administration on the clinical activity in patients with advanced gastric cancer
by: Xiaoyun Zhang, et al.
Published: (2021-01-01)

Impact of the time of surgical delay on survival in patients with muscle-invasive bladder cancer
by: Shuaishuai Li, et al.
Published: (2022-12-01)